Увійти

Готові списки джерел за темами / Chronic hepatitis B virus infection / Книги

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Chronic hepatitis B virus infection.

Книги з теми "Chronic hepatitis B virus infection"

Автор: Grafiati

Опубліковано: 7 червня 2025

Оновлено: 2 серпня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 книг для дослідження на тему "Chronic hepatitis B virus infection".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте книги для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Tang, Hong, ed. Hepatitis B Virus Infection. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-13-9151-4.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

1944-, Gerlich W. H., ed. Research in chronic viral hepatitis. Springer-Verlag, 1993.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Goh, Kee Tai. Epidemiology and control of hepatitis B virus infection in Singapore. Southeast Asian Medical Information Center, International Medical Foundation of Japan, 1992.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Goh, K. T. Epidemiology and control of hepatitis B virus infection in Singapore. Southeast Asian Medical Information Center, 1992.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

San Francisco (Calif). Dept. of Public Health. Communicable Disease Control Unit. Chronic hepatitis B and hepatitis C infection surveillance report: 2009, San Francisco, California. San Francisco Department of Public Health, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

San Francisco (Calif). Dept. of Public Health. Communicable Disease Control Unit. Chronic hepatitis B and hepatitis C infection surveillance report: 2010, San Francisco, California. San Francisco Department of Public Health, 2012.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

1953-, Hamatake Robert Kiyoshi, and Lau Johnson Y. N, eds. Hepatitis B and D protocols. Humana Press, 2004.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

San Francisco (Calif.). Dept. of Public Health. Communicable Disease Control Unit. Registry match: Chronic hepatitis B, hepatitis C infection and HIV : 2010, San Francisco, California. San Francisco Department of Public Health, 2011.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Green, William Finley. The first year-- hepatitis B: An essential guide for the newly diagnosed. Marlowe & Co., 2002.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Husereau, Donald Robert. Interferon-based therapies for chronic hepatitis C virus infection: An assessment of clinical outcomes. Canadian Coordinating Office for Health Technology Assessment, 2004.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Bruce, Brady, and Canadian Agency for Drugs and Technologies in Health., eds. Pegylated interferon combined with ribavirin for chronic hepatitis c virus infection: An economic evaluation. Canadian Agency for Drugs and Technologies in Health, 2007.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Tong, Hoang Van. Functional roles of host genetic polymorphism in Hepatitis B virus infection and clinical outcomes. s.n.], 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Lindh, Gudrun. Chronic hepatitis B: Impact of hepatitis D virus superinfection and the hepatitis B e-system on histological outcome, and correlation of the hepatitis B e-system to HBV-DNA in serum. Distributed by the Almqvist & Wiksell Periodical Co., 1986.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

institutet, Karolinska, ed. Chronic hepatitis B: Impact of hepatitis D virus superinfection and the hepatitis B e-system on histological outcome, and correlation of the hepatitis B e-system to HBV-DNA in serum. Distributed by Almqvist & Wiksell Periodical Co., 1986.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Kourtis, Athena P., Shruti Chandramouli, Gonzague Jourdain, and Marc Bulterys. Hepatitis B Virus. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190604813.003.0004.

Повний текст джерела

Анотація:

Hepatitis B virus (HBV) is the most common cause of chronic viral hepatitis and hepatocellular carcinoma in the world. Worldwide, more than 250 million people are chronically infected with HBV, causing nearly 780,000 deaths each year, and mother-to-child transmission (MTCT) accounts for more than one-third of chronic HBV infections. Universal vaccination in neonates is the most effective strategy for eliminating infections worldwide. Maternal antiviral treatment during the antepartum/postpartum period for mothers with high HBV viral loads is effective in preventing HBV MTCT. Full immunization

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Beattie, R. Mark, Anil Dhawan, and John W.L. Puntis. Hepatitis B. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780198569862.003.0057.

Повний текст джерела

Анотація:

Epidemiology 418Transmission 418Clinical features 418Interpretation of HBV serology 419Complications 419Prevention 421Management of chronic HBV infection 422• About 2 billion people (1/3 of the world population) show evidence of exposure to hepatitis B virus (HBV) infection, with 300–400 million showing evidence of chronic HBV infection....

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Barnett, Ben J., and Margaret Hoffman-Terry. HIV/Hepatitis Co-infection. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0039.

Повний текст джерела

Анотація:

Hepatitis B virus (HBV) infection is common in people living with HIV, and all patients with HIV should be screened for HBV infection. The most common route of transmission worldwide is through perinatal or early childhood exposure, but adult transmission of HBV is often by routes similar to those for HIV, including sexual contact and injection drug use. Although it varies by exposure route, approximately 10% of HIV-positive patients also have chronic HBV infection, and up to 90% have serologic evidence of past exposure to HBV. Long-term complications of HBV infection can include cirrhosis, en

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Keshav, Satish, and Palak Trivedi. Viral hepatitis. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0212.

Повний текст джерела

Анотація:

Hepatitis means ‘inflammation of the liver’ and is manifest with symptoms that include malaise, anorexia, fever, flu-like symptoms, and pain in the right upper quadrant of the abdomen, with the pain being caused by swelling of the liver and its capsule. Elevations in circulating hepatic enzymes, particularly aspartate transaminase and alanine transaminase, are common, with jaundice occurring some time after the onset of other symptoms and signs. There are five viruses that primarily cause viral hepatitis: hepatitis A, B, C, D, and E viruses, abbreviated HAV, HBV, HCV, HDV, and HEV, respectivel

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Proceedings of an International Symposium on Anti-Viral Agents in Chronic Hepatitis B Virus Infection. Elsevier Science & Technology, 1986.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Van Calsteren, Kristel. Chronic maternal infections. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198713333.003.0050.

Повний текст джерела

Анотація:

Pregnant women diagnosed with chronic infections are a worldwide problem. In developed countries, the most frequently encountered are hepatitis B and C, toxoplasmosis, syphilis, herpes simplex, and Cytomegalovirus infections. In developing countries, human immunodeficiency virus and malaria are also seen commonly in pregnant women. Maternal infections are associated with various complications in pregnant women, but also with congenital infections with or without structural anomalies and long-term sequelae, fetal growth restriction, preterm delivery, and perinatal mortality. Moreover, increasin

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Wilson, Deanna. Hepatitis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0035.

Повний текст джерела

Анотація:

Hepatitis A (HAV) and E (HEV) viruses are spread via the fecal-oral route. Hepatitis B virus (HBV) exposure is via occupational or recreational activities. Hepatitis D virus (HDV; also spread parentally) can only coinfect or superinfect those with chronic HBV. Hepatitis C (HCV) transmission is predominantly parenteral; the highest risk group is injection drug users. Prodromal-period patients with acute hepatitis present with vague constitutional symptoms when serum transaminases peak, with elevated serum bilirubin and varying levels of hepatic protein synthesis impairment; during the icteric p

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Cooke, Graham. Viral infection. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0308.

Повний текст джерела

Анотація:

Viral infection includes any clinical illness caused by a pathogenic virus. Acute viral infections are amongst the most common illnesses of humans and range from minor upper respiratory tract infections to viral haemorrhagic fever. The principles in diagnosing acute viral infection are, first, recognize the syndrome, then identify key features that might suggest a specific diagnosis, and, finally, consider laboratory investigations to elucidate the specific causative agent. The host–pathogen response determines different outcomes for specific viral infections. After infection with some viruses

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Franceschi, Silvia, Hashem B. El-Serag, David Forman, Robert Newton, and Martyn Plummer. Infectious Agents. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0024.

Повний текст джерела

Анотація:

Eleven infectious agents (seven viruses, three parasites, and one bacterium) have been classified by the International Agency for Research on Cancer as carcinogenic to humans for one or more cancer sites: hepatitis B virus; hepatitis C virus; thirteen types of human papillomavirus (HPV); human immunodeficiency virus type 1 (HIV-1); human T-cell leukemia virus type 1; Epstein-Barr virus; Kaposi sarcoma herpesvirus; Helicobacter pylori; Opisthorchis viverrini; Clonorchis sinensis; and Schistosoma haematobium. Other infectious agents, such as Merkel cell polyomavirus, Plasmodium falciparum, and c

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Thomas London, W., Jessica L. Petrick, and Katherine A. McGlynn. Liver Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0033.

Повний текст джерела

Анотація:

Primary liver cancer is the sixth most frequently occurring cancer in the world and the second most common in terms of cancer deaths. The global burden of liver cancer is borne principally by countries in East Asia and Africa, where 80% of liver cancer arises. Incidence rates of liver cancer, however, have begun to decline in Asia, while rates are increasing in low-rate areas such as Europe and North America. The dominant histology of liver cancer in almost all countries is hepatocellular carcinoma (HCC). The major risk factors for HCC—chronic infection with either hepatitis B virus (HBV) or h

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Chronic Hepatitis B. W.B. Saunders Company, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Thun, Michael J., Martha S. Linet, James R. Cerhan, Christopher Haiman, and David Schottenfeld. Primary Prevention of Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0062.

Повний текст джерела

Анотація:

Primary prevention has enormous potential to reduce the human, social, and economic costs of cancer worldwide. The following sections discuss the development and application of preventive interventions in six broad areas of public health: tobacco control, the prevention of obesity and physical inactivity, prevention of infection-related cancers, protection against excessive exposure to ultraviolet light, preventive drug therapies (chemoprevention), and the regulation of carcinogenic exposures. All of these areas affect multiple types of cancer and massive numbers of people. Different intervent

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Seeger, Christoph, and Stephen Locarnini. Hepatitis B and Delta Viruses. Cold Spring Harbor Laboratory Press, 2015.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Ning, Qin. Acute Exacerbation of Chronic Hepatitis B: Volume 2. Diagnosis and Management. Springer, 2019.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Thun, Michael J., Christopher P. Wild, and Graham Colditz. Framework for Understanding Cancer Prevention. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0061.

Повний текст джерела

Анотація:

The worldwide increase in the number of people affected by cancer and the costs of cancer care has increased the urgency of efforts to translate knowledge about the causes of cancer into effective preventive interventions. A wide range of interventions has proven to be effective for cancer prevention, either by reducing exposure to known causes of human cancer or by disrupting the multistage progression of tumors. Examples of progress include the up to 40% decrease in the age-standardized lung cancer incidence rate among men in high- and middle-income countries due to tobacco control; the 30%

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Tang, Hong. Hepatitis B Virus Infection: Molecular Virology to Antiviral Drugs. Springer, 2020.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Tang, Hong. Hepatitis B Virus Infection: Molecular Virology to Antiviral Drugs. Springer, 2019.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Tang, Hong. Hepatitis B Virus Infection: Molecular Virology to Antiviral Drugs. Springer, 2019.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Ning, Qin. Acute Exacerbation of Chronic Hepatitis B: Volume 1. Definition, Research Technology, Virology, Genetics and Immunology. Springer, 2019.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Ning, Qin. Acute Exacerbation of Chronic Hepatitis B: Volume 1. Definition, Research Technology, Virology, Genetics and Immunology. Springer, 2019.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Chronic Viral Hepatitis: Diagnosis and Therapeutics. Humana, 2012.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Wu, George Y., Kirti Shetty, and Raymond S. Koff. Chronic Viral Hepatitis: Diagnosis and Therapeutics. Humana Press, 2001.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Hepatitis B and d Protocols Vol. 2 : Volume 2: Immunology, Model Systems, and Clinical Studies. Humana Press, 2004.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Lu, Mengji, Zhongji Meng, Jia Liu, and Anna D. Kosinska, eds. Targeting the Immune System to Treat Hepatitis B Virus Infection. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-856-3.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Krogsgaard, Kim. Hepatitis B virus DNA in serum: Applied molecular biology in the evaluation of hepatitis B infection. 1988.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Lau, Johnson Y. N., and Robert K. Hamatake. Hepatitis B and D Protocols Vol. 2: Immunology, Model Systems, and Clinical Studies. Humana Press, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Bansal, Sanjay. Hepatitis B. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198759928.003.0063.

Повний текст джерела

Анотація:

The chapter on hepatitis B discusses the epidemiology and transmission of this infection. It covers the clinical features, complications, and prevention of the disease, but also the interpretation of the serology as well the management of the chronic hepatitis B infection.

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Hepatitis B and D Protocols: Volume 2: Immunology, Model Systems, and Clinical Studies (Methods in Molecular Medicine). Humana Press, 2004.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Hepatitis B and D Protocols: Volume 1: Detection, Genotypes, and Characterization (Methods in Molecular Medicine). Humana Press, 2004.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Huyton, Rita, Sam Ghebrehewet, and David Baxter. Hepatitis B. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198745471.003.0006.

Повний текст джерела

Анотація:

This chapter describes an acute hepatitis B case and scenario involving a paramedic with a pregnant woman as close sexual contact and potential risk of transmission to the unborn baby. Background information on the epidemiology of Hepatitis B, markers of hepatitis B infection (both acute and chronic), and the risk factors for transmission are discussed. There are clear case definitions of acute, chronic, and those susceptible and at high risk for hepatitis B plus detailed interpretation of hepatitis B markers. ‘Top tips’ are given to assist the relevant clinicians or public health/health prote

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Muche, Marion, and Seema Baid-Agrawal. Hepatitis B. Edited by Vivekanand Jha. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0185_update_001.

Повний текст джерела

Анотація:

Hepatitis B virus (HBV) has been causally linked to a variety of renal diseases, the most common being glomerular diseases and systemic autoimmune disease. Membranous nephropathy (MN) is the commonest HBV-associated glomerulonephritis (HBV-GN), followed by membranoproliferative glomerulonephritis (MPGN), mesangial proliferative glomerulonephritis, immunoglobulin (Ig)-A nephropathy, and focal segmental glomerulosclerosis (FSGS). Polyarteritis nodosa is a rare manifestation. The incidence of HBV-associated renal diseases seems to be decreasing with the introduction of vaccination programmes.HBV-

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Honegger, Jonathan R. Hepatitis C Virus. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190604813.003.0005.

Повний текст джерела

Анотація:

An estimated 185 million individuals have been infected with hepatitis C virus (HCV) worldwide. Although often clinically silent for decades, chronic HCV infection predisposes to late-onset complications, including liver cirrhosis and hepatocellular carcinoma. Mother-to-child transmission (MTCT) of HCV affects approximately 5% of children born to viremic mothers and is the primary route of HCV infection in young children. While some vertically acquired HCV infections are resolved during the first years of life, many persist indefinitely. Chronically infected children tend to be asymptomatic an

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Yan, Chan Camie Wing. The roles of fgl2 in innate and acquired immunity: Implications in chronic hepatitis B infection. 2003.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Price, Jennifer Cohen, Priyanka Amin, and Antoine Douaihy. Hepatitis C and HIV Co-Infection. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0043.

Повний текст джерела

Анотація:

Chronic infection with hepatitis C virus (HCV) is a leading cause of end-stage liver disease and is the most common indication for liver transplantation in the United States. Because of shared risk factors, individuals living with HIV infection are disproportionately affected by HCV. Moreover, co-infection with HIV accelerates the natural history of chronic HCV infection, increasing the risk of cirrhosis, hepatocellular carcinoma, hepatic decompensation, and death. Highly effective medications such as direct-acting antivirals (DAA) to cure HCV are now available and have the potential to profou

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Kan, Xuegui. Relationship between alcohol consumption and hepatitis B virus (HBV) infection as risk factors in liver cirrhosis. 1985.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

50

ANOCHIE, Philip. Role of the Markers of Hepatitis B Virus Infection in the Clinical Management of the Disease. Lulu Press, Inc., 2018.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!